EN
HI
Summary
As of 7 Sep, 2026, Aurobindo Pharma stock price is ₹1660. During the trading session, the stock has moved between an intraday low of ₹1646.00 and an intraday high of ₹1668.00. Over the last 52 weeks, Aurobindo Pharma has traded between ₹1021.00 and ₹1717.00.
The stock has recorded a trading volume of 5,36,717 shares, with a market capitalization of ₹575377895. Its Average Traded Price (ATP) is ₹1657.16, while the Last Traded Quantity at the Last Traded Price (LTQ@LTP) is 72 @ ₹1660.00.
Aurobindo Pharma has an upper circuit limit of ₹1818.40 and a lower circuit limit of ₹1487.80. The total value traded stands at ₹88.94 CR, and the delivery percentage for the day is 38.93%.
The stock is currently traded with a market lot size of 1. Aurobindo Pharma also offers a dividend yield of 0.24%.
Aurobindo Pharma share price chart
Aurobindo Pharma Share Key Metrics
Volume
5.37 L
Market Cap
95115.72 CR
LTQ@LTP
72@1660.00
ATP
1657.16
Var Margin
14.35 %
Circuit Range
1487.8-1818.4
Delivery %
38.93 %
Value
88.94 CR
ASM/GSM
No
Market Lot
1
Aurobindo Pharma Fundamentals
P/E Ratio
25.62
P/B Ratio
2.44
Div. Yield
0.24
Sector P/E
41.43
Sector P/B
3.55
Sec. Div. Yield
0.5
Aurobindo Pharma Resistance and Support
Pivot 1645.73
Resistance
First Resistance
1668.86
Second Resistance
1684.63
Third Resistance
1707.76
Support
First Support
1629.96
Second Support
1606.83
Third Support
1591.06
Aurobindo Pharma Futures & Options
Aurobindo Pharma Option Chain
View Price, OI, Greeks & More...
29SEP26
1666.70
1.70 (0.10%)
27OCT26
1674.30
-0.50 (0.03%)
23NOV26
1681.80
-1.70 (0.10%)
AUROPHARMA|29SEP26 CE 1640.00
52.55
-3.25 (-5.82%)
AUROPHARMA|29SEP26 PE 1660.00
37.2
-2.35 (-5.94%)
Aurobindo Pharma Historical Data
| Day | Open | Close | Change(%) | Day High | Day Low |
|---|---|---|---|---|---|
| Mon Sep 07 2026 | 1646 | 1660 | 0.42% | 1668 | 1646 |
| Fri Sep 04 2026 | 1637.3 | 1653.09 | 0.96% | 1661.5 | 1622.59 |
| Thu Sep 03 2026 | 1656.09 | 1637.3 | -0.66% | 1666.59 | 1626.59 |
Aurobindo Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-08-05 | Quarterly Results |
| 2026-05-21 | Audited Results |
| 2026-04-06 | Buy Back of Shares |
| 2026-02-09 | Quarterly Results |
| 2025-11-05 | Quarterly Results |
| 2025-08-04 | Quarterly Results & Interim Dividend |
| 2025-05-26 | Audited Results |
| 2025-02-06 | Quarterly Results |
| 2024-11-09 | Quarterly Results |
| 2024-08-10 | Quarterly Results |
Aurobindo Pharma News
Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Unit-VI Of Apitoria Pharma Private Limited, A Wholly Owned Subsidiary Of The Company
Aurobindo Pharma's wholly owned subsidiary, Apitoria Pharma Private Limited, completed a US FDA inspection at its Unit-VI API manufacturing facility. The inspection resulted in three procedural observations, to which the company will respond within the stipulated timeline.
Aug 28 2026 15:34:45
Aurobindo Pharma Ltd - 524804 - Completion Of US FDA Inspection At Lannett Company LLC, A Wholly Owned Subsidiary Of Aurobindo Pharma USA, Inc.
Aurobindo Pharma's wholly-owned subsidiary, Lannett Company LLC, concluded a routine US FDA inspection at its Seymour, IN facility with four observations. The company stated these observations are procedural in nature and will be addressed within the stipulated timeline.
Aug 24 2026 09:08:11
Read More
Aurobindo Pharma Management
| Name | Position |
|---|---|
| Mangalam Ramasubramanian Kumar | Chairman |
| K Nityananda Reddy | Vice Chairman & Managing Director |
Aurobindo Pharma Similar Stocks
Lupin Ltd.
2105.00
-5.00 (0.24%)
Dr. Reddy's Laboratories Ltd.
1144.20
-6.80 (0.59%)
Mankind Pharma Ltd.
2318.00
-9.90 (0.43%)
Manipal Health Enterprises Ltd.
727.25
2.05 (0.28%)
Max Healthcare Institute Ltd.
992.00
7.20 (0.73%)
Fortis Healthcare Ltd.
910.00
5.00 (0.55%)
Aster DM Quality Care Ltd.
795.65
9.90 (1.26%)
Glenmark Pharmaceuticals Ltd.
2451.90
14.70 (0.60%)
Biocon Ltd.
391.40
-6.00 (1.51%)
Alkem Laboratories Ltd.
5242.50
52.50 (1.01%)
Aurobindo Pharma FAQs
The Buying Price of Aurobindo Pharma share is 1660 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Aurobindo Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Aurobindo Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Aurobindo Pharma shares is 25.62. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Aurobindo Pharma shares is 2.44. Useful to assess the stock's value relative to its book value.
To assess Aurobindo Pharma’s valuation compare Sector P/E, P/B which are 41.43 & 3.55 with sector averages, along with growth rates and financial metrics.
The Market Cap of Aurobindo Pharma is 95115.72 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Aurobindo Pharma share price is 1717.00 & 1021.00. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Aurobindo Pharma belongs to the Healthcare sector.
Open Your Free
Demat Account Now!
AMC for First Year- Auto Square Off Charges
13 Lakh+ Clients
Expert-Backed
Premium Tools
Open Your Free
Demat Account Now!
- AMC For First Year
- Account Opening Fee
- 13 Lakh+ Clients
- Expert-Backed
- Premium Tools
Invest in AUROPHARMA
Or Download Choice FinX App
Invest in AUROPHARMA
Account Opening Fee- AMC for 1st Year
- Auto Square Off Charges
- Call & Trade